Sex differences in effectiveness of first-line tumor necrosis factor inhibitors in axial spondyloarthritis; results from fifteen countries in the EuroSpA research collaboration network

Pasoon Hellamand, Marleen G H Van de Sande, Lykke Midtbøll Ørnbjerg, Thomas Klausch, Michael Nurmohamed, R Van Vollenhoven, D.C. Nordström, Anna-Mari Hokkanen, MJ Santos, Elsa Vieira-Sousa, A. G. Loft, Bente Glintborg, Mikkel Østergaard, U Lindström, Johan Karlsson Wallman, Brigitte Michelsen, Adrian Ciurea, M. J. Nissen, Catalin Codreanu, C MoogosanG. Macfarlane, G. T. Jones, Karin Laas, Z Roter, M Tomsic, I Castrejon, M Pombo-Suarez, B Gudbjörnsson, A. J. Geirsson, E. Kristianslund, J. Vencovsky, Lucie Nekvindova, S Gulle, B Zengin, Merete Lund Hetland, I Van der Horst- Bruinsma

Abstract

Sex differences in effectiveness of first-line tumor necrosis factor inhibitors in axial spondyloarthritis; results from fifteen countries in the EuroSpA research collaboration network
OriginalsprogEngelsk
Publikationsdato2022
StatusUdgivet - 2022
BegivenhedEULAR 2022 - Copenhagen
Varighed: 1 jun. 20224 jun. 2022

Konference

KonferenceEULAR 2022
ByCopenhagen
Periode01/06/202204/06/2022

Citationsformater